AAOS selects graduate Maher Ghandour as best resident doctor
The Faculty of Medical Sciences was established under Decree No. 1118/12 in October 1983, and it plays a leading role in education, research and development in various fields of medical care in cooperation with local and external academic and health institutions.
Since its establishment, the Faculty of Medical Sciences paved the way for outstanding young men and women in Lebanon to achieve their ambitions to study medicine, and graduated the best physicians who enjoy high scientific competence, integrated training and high professional ethics.
The Faculty of Medical Sciences seeks to obtain full and comprehensive international accreditation at the level of patient care, medical education and research. It also works to maintain the confidence of the Lebanese public in it through the quality of its clinical, educational and research programs to serve all of these national and international health care needs.
The Neuroscience Research Center (NRC) is affiliated to the faculty and aims to enhance the educational attainment of students in neuroscience specializations, in line with the needs of the university and public and private hospitals.
Several applied and research laboratories are also affiliated to the faculty, including: Biology Laboratory, Histology Laboratory, Immunology Laboratory, Chemistry Laboratory, Bacteriology Laboratory, Molecular Biology Laboratory, Physiology Laboratory, ENT Laboratory, Laparoscopy Laboratory, Gynecology Simulator Laboratory, Cardiology Simulator Laboratory
The faculty grants the following degrees:
The Neuroscience Research Center grants the following degrees:
Students accepted in the MRC/FMS for the academic year 2023-2024
Students accepted in the NRC / FMS for the academic year 2023-2024
The NRC in FMS is accepting electronic applications for new students for the academic year 2023-2024
The MRC in FMS is accepting electronic applications for new students for the academic year 2023-2024
Apply for the "State of Kuwait Prize for the Control of Cancer, Cardiovascular Diseases and Diabetes" before 1 July 2023